- 2401-Introduction
- 2402-The Deposit Rules
- 2403-Deposit of Biological Material
- 2404-Need or Opportunity to Make a Deposit
- 2405-Acceptable Depository
- 2406-Time of Making an Original Deposit
- 2407-Replacement or Supplement of Deposit
- 2408-Term of Deposit
- 2409-Viability of Deposit
- 2410-Furnishing of Samples
- 2411-Examination Procedures
- 2412-The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures to Include
a Sequence Listing in XML file format
- 2412.01-Overview of the Sequence Rules
- 2412.02-Definition of “Sequence Listing XML”
- 2412.03-Nucleotides and Amino Acids Included and Excluded From a “Sequence Listing XML”
- 2412.04-Use of Sequence Identifiers to Denote Sequences Disclosed in the Description or Claims
- 2412.05-Representation and Symbols for Nucleotide and/or Amino Acid Sequences
- 2412.05(a)-Use of Sequentially Numbered Sequence Identifiers in the “Sequence Listing XML”
- 2412.05(b)-Representation and Symbols of Nucleotide Sequence Data
- 2412.05(c)-Representation and Inclusion of Variants
- 2412.05(d)-Representation and Symbols of Amino Acid Sequence Data
- 2412.05(e)-Presentation of Special Situations
- 2412.06-The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
- 2412.07-Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
- 2413-Content of “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File
- 2413.01-Parts of the “Sequence Listing XML”
- 2413.01(a)-The “Sequence Listing XML” is a Single File Encoded Using Unicode UTF-8
- 2413.01(b)-The “Sequence Listing XML” Must Be Valid According To the DTD
- 2413.01(c)-The “Sequence Listing XML” Must Contain an XML Declaration
- 2413.01(d)-The “Sequence Listing XML” Must Contain a DOCTYPE Declaration
- 2413.01(e)-The “Sequence Listing XML” Must Contain a Root Element
- 2413.01(f)-The “Sequence Listing XML” Must Contain a General Information Part
- 2413.01(g)-The “Sequence Listing XML” Must Contain a Sequence Data Part
- 2413.01(h)-Language Dependent Free Text Qualifiers in the English Language
- 2413.01(i)-Title Element in “Sequence Listing XML”
- 2413.02-Form and Format of the XML file containing the “Sequence Listing XML”
- 2413.03-How to Submit the “Sequence Listing XML”
- 2413.04-Requirements Regarding Incorporation By Reference of the “Sequence Listing XML”
- 2413.05-Presumptions Regarding Compliance
- 2413.01-Parts of the “Sequence Listing XML”
- 2414-Notification of a Failure to Comply with Sequence Listing Requirements and Amendments Relating to “Sequence Listing XML” Files
Under 37 CFR 1.835
- 2414.01-Issuance of a Notice Relating to the Requirements For Patent Applications Containing Nucleotide and/or Amino Acid Sequence Disclosures
- 2414.02-Amendment to Add an Initial “Sequence Listing XML” under 37 CFR 1.835(a)
- 2414.03-Amendment Adding to, Deleting from, or Replacing Sequence Information in a “Sequence Listing XML” under 37 CFR 1.835(b)
- 2414.04-Translation of “Sequence Listing XML” is Not an Amended “Sequence Listing XML” under 37 CFR 1.835(b)
- 2414.05-Notifications for Failure to Submit a “Sequence Listing XML” in an International Application under the PCT to be Searched by the United States International Searching Authority or Examined by International Preliminary Examination Authority
- 2414.06-Compliance with “Sequence Listing XML” for Any Amendment to a Patent
- 2415-Applicability date of “Sequence Listing XML” Requirements to Applications Based on Filing Date of Application and Procedures
for Failure to Submit Correct Format of Sequence Listing
- 2415.01-Determining when a Sequence Listing in XML format must be submitted
- 2415.02-Provisional Applications Containing Disclosures of Nucleotides and/or Amino Acids, Compliance with 37 CFR 1.831-1.834
- 2415.03-Improper Submissions of “Sequence Listing” under 1.821(c)(1)-(3) When a “Sequence Listing XML” was Required
- 2416-Form Paragraphs
- 2417-[Reserved]
- 2418-WIPO Sequence Tool
- 2419-Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”
- 2419.01-Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML”
- 2419.02-Patent Grants and Patent Application Publications Containing a Lengthy “Sequence Listing XML”
- 2419.03-Patent Grants and Patent Application Publications Containing a “Sequence Listing XML” of 1GB or Larger
- 2420-The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures under World Intellectual Property Office Standard ST.25 (WIPO ST.25) - the Sequence Rules
- 2421-Overview of the Sequence Rules under WIPO ST.25
- 2422-Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications Subject to WIPO ST.25
- 2422.01-Nucleotide and/or Amino Acids Disclosures Requiring a “Sequence Listing”
- 2422.02-The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
- 2422.03-Sequence Listing Submission
- 2422.03(a)-“Sequence Listing” Submitted as ASCII Plain Text Files
- 2422.04-The Requirement for a Computer Readable Copy of the “Sequence Listing”
- 2422.05-[Reserved]
- 2422.06-Requirement for Statement Regarding Information Contained in the “Sequence Listing” and Separate Computer Readable Form
- 2422.07-Requirements for Compliance and Consequences of Non-Compliance
- 2422.08-Presumptions Regarding Compliance
- 2422.09-[Reserved]
- 2423-Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data for WIPO ST.25
- 2424-Requirements for Content of a “Sequence Listing” Part of the Specification under WIPO ST.25.
- 2425-Form and Format for a Nucleotide and/or Amino Acid Sequence Submission as an ASCII Plain Text File under WIPO ST.25
- 2426-Amendments to Add or Replace a “Sequence Listing” and CRF Copy Thereof Subject to WIPO ST. 25
- 2427-Form Paragraphs for Applications Subject to WIPO ST.25
- 2428-Sample Statements under WIPO ST.25
- 2429-Helpful Hints for Sequence Rules Compliance under WIPO ST.25
- 2430-PatentIn Information
- 2431-Sample “Sequence Listing” under WIPO ST.25
- 2432-[Reserved]
- 2433-Box Sequence; Hand Delivery of a “Sequence Listing” and Computer Readable Forms
- 2434-Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
- 2435-Publishing of Patents and Patent Application Publications with a Lengthy “Sequence Listing”
This page is owned by Patents.
Last Modified:
02/16/2023 12:58:24